Wednesday, January 28, 2026
Pfizer Invites Investors and the Public to Webcast with CEO Albert Bourla at the 2026 J.P. Morgan Healthcare Conference
The biopharmaceutical company Pfizer has announced that it will invite investors and the general public to attend a live webcast. The event will feature a discussion with Albert Bourla, Chairman and Chief Executive Officer of Pfizer, held as part of the J.P. Morgan Healthcare Conference.
The discussion will take place on Monday, January 12, 2026, at 9:45 a.m. PST and is considered one of the most important annual gatherings for investors, analysts, and decision-makers in the global healthcare sector. Once again, Pfizer demonstrates its strong commitment to transparency and open dialogue with the capital markets.
The webcast will be accessible via the Investor Relations section of Pfizer’s website. Registration and access details are already available online. For those unable to attend live, Pfizer will provide a full replay and transcript within 24 hours after the discussion concludes. These materials will remain available for at least 90 days.
The discussion is expected to offer insights into the company’s strategic direction, the development of its product pipeline, and current market and innovation priorities. Such appearances give investors a valuable opportunity to gain first-hand insights into Pfizer’s long-term vision and strategic priorities.
As one of the world’s leading biopharmaceutical companies, Pfizer has been committed for more than 175 years to translating scientific breakthroughs into therapies that significantly improve patients’ lives.